Home FOLDAX®

FOLDAX®

Foldax® Closes $20 Million Financing

MemorialCare Innovation Fund led the round, with Angel Physicians Fund and Sayan Bioventures joining as new investors.

Enrollment in Tria LifePolymer™ Early Feasibility Study Completed

Fifteen patients have been enrolled in the Tria LifePolymer early feasibility study reports FOLDAX.

Foldax Tria LifePolymer™ Heart Valve Technology Honored with The Best Innovation Award at CRT 2020

Tria LifePolymer heart valves are made with LifePolymer, a novel, patented biopolymer developed specifically for heart valve application.